Vijaya diagnostics logs 25% yoy decline in PAT at Rs23.70 crore for Q4FY22; stock plunges ~4%

27 May 2022 , 03:40 PM

Vijaya Diagnostic Centre Limited, one of India’s leading integrated diagnostic chains, has announced its financial results for the quarter and twelve months ended March 31, 2022.

The company has reported a 23% yoy increase in revenue at Rs462.40 crore in FY22 as compared to Rs376.70 crore in FY21. For Q4FY22, the company reported growth of 4% yoy at Rs116.20 crore as against Rs112 crore in Q4FY21.

Company’s EBITDA for Q4FY22 was Rs47.90 crore as compared to Rs54.40 crore, down by 12% yoy. For FY22, EBITDA stood at Rs203.70 crore as against Rs166 crore in the previous financial year, a growth of 23% yoy.

PAT for the quarter under review stood at Rs23.70 crore, registering a decline of 25% yoy against Rs31.40 crore in Q4FY21. It logged growth of 30% yoy in PAT at Rs109.70 crore in FY22 as against Rs84.50 crore in FY21.

EBITDA margin for Q4 & FY22 were 44.10% and 41.20% respectively.

Vijaya Diagnostic ended at Rs381.35 down by Rs14.1 or 3.57% from its previous closing of Rs395.45 on the BSE. The scrip touched day’s high and low of Rs405.65 and Rs376 respectively.